Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
56.75
-0.27 (-0.47%)
At close: Jan 30, 2026

Revenue

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Roche Pharmaceuticals Revenue
44.59B43.30B
Chugai Revenue
2.93B2.87B
Pharmaceuticals Revenue
47.52B46.17B
Diagnostics Revenue
14.07B14.32B

Revenue by Geography

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Switzerland Revenue
747.00M
Germany Revenue
2.93B
Rest of Europe Revenue
10.29B
Europe Revenue
13.97B
United States Revenue
28.90B
Rest of North America Revenue
889.00M
North America Revenue
29.79B
Latin America Revenue
3.25B
Japan Revenue
3.15B
Rest of Asia Revenue
9.09B
Asia Revenue
12.24B
Africa, Australia and Oceania Revenue
1.25B

EBIT

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Roche Pharmaceuticals Operating Profit
14.13B12.34B
Chugai Operating Profit
3.16B3.21B
Pharmaceuticals Operating Profit
17.63B15.59B
Diagnostics Operating Profit
1.24B1.95B
Corporate Operating Profit
-4.19B-4.12B

Capital Expenditures

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Roche Pharmaceuticals Capital Expenditures
4.98B6.00B
Chugai Capital Expenditures
476.00M350.00M
Pharmaceuticals Capital Expenditures
5.45B6.35B
Diagnostics Capital Expenditures
2.45B2.44B
Corporate Capital Expenditures
66.00M78.00M
Updated Jun 30, 2025. Data Source: Fiscal.ai.